Advertisement News Archives - Page 1596 of 5228 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

July 16, 2026

Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy

Harbour BioMed and Kelun-Biotech have received approval from China’s National Medical Products Administration (NMPA) for their investigational new drug (IND) application for the HBM7575/SKB575 bispecific antibody intended to treat asthma.

Harbour BioMed and Kelun-Biotech receive China IND approval for asthma therapy